Allogene Therapeutics, Inc.
ALLO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001737287
In the last 90 days, Allogene Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 209 institutions reported holding it in 13F filings for Q2 2026, worth $652.0M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Allogene Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 209
- +39 vs. Q4 2025
- Shares held
- 184.2M
- +30.8M (+20.1%) vs. Q4 2025
- Total value
- $444.7M
- +$234.7M (+111.7%) vs. Q4 2025
- New holders
- 51
- 80 more added
- Sold out
- 12
- 40 more reduced
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALLO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 209 | $652.0M |
| Q1 2026 | 209 | $444.7M |
| Q4 2025 | 172 | $222.7M |
| Q3 2025 | 170 | $201.0M |
| Q2 2025 | 158 | $207.9M |
| Q1 2025 | 171 | $288.5M |
| Q4 2024 | 174 | $401.9M |
| Q3 2024 | 156 | $460.4M |
| Q2 2024 | 175 | $385.1M |
| Q1 2024 | 161 | $586.0M |
| Q4 2023 | 170 | $392.4M |
| Q3 2023 | 155 | $413.3M |
| Q2 2023 | 171 | $662.9M |
| Q1 2023 | 176 | $582.3M |
| Q4 2022 | 168 | $700.9M |
| Q3 2022 | 192 | $1.15B |
| Q2 2022 | 161 | $1.15B |
| Q1 2022 | 180 | $836.7M |
| Q4 2021 | 177 | $1.28B |
| Q3 2021 | 169 | $2.26B |
| Q2 2021 | 182 | $2.25B |
| Q1 2021 | 169 | $3.12B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Allogene Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Pfizer Inc | 22,032,040 | $49.8M | 20.85% | 00.0% | Unchanged |
| BlackRock, Inc. | 19,091,095 | $46.6M | 0.00% | +1,415,066+8.0% | Added |
| TPG GP A, LLC | 18,716,306 | $45.7M | 1.24% | 00.0% | Unchanged |
| State Street Corp | 8,660,306 | $21.1M | 0.00% | +5,898,906+213.6% | Added |
| Primecap Management Co | 8,379,840 | $20.4M | 0.02% | +240,000+2.9% | Added |
| Vanguard Capital Management LLC | 6,921,350 | $16.9M | 0.00% | +6,921,350 | New |
| Citadel Advisors LLC | 6,793,620 | $16.6M | 0.01% | −5,317,800−43.9% | Reduced |
| Price T Rowe Associates Inc | 5,380,902 | $13.1M | 0.00% | +2,171,627+67.7% | Added |
| Two Sigma Investments, LP | 5,375,456 | $13.1M | 0.01% | +1,952,015+57.0% | Added |
| Geode Capital Management, LLC | 4,124,178 | $10.1M | 0.00% | +191,268+4.9% | Added |
| Frazier Life Sciences Management, L.P. | 3,796,668 | $9.26M | 0.24% | −72,082−1.9% | Reduced |
| Woodline Partners LP | 3,501,078 | $8.54M | 0.03% | +5790.0% | Added |
| Patient Square Capital LP | 3,450,000 | $8.42M | 1.49% | −1,513,756−30.5% | Reduced |
| Marshall Wace, LLP | 3,447,984 | $8.41M | 0.01% | +3,162,423+1,107.4% | Added |
| Millennium Management LLC | 3,322,053 | $8.11M | 0.01% | +1,480,746+80.4% | Added |
| Candriam Luxembourg S.C.A. | 2,997,318 | $7.31M | 0.04% | +691,674+30.0% | Added |
| Wildcat Capital Management, LLC | 2,920,787 | $7.13M | 6.71% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 2,766,244 | $6.75M | 0.00% | +476,786+20.8% | Added |
| D. E. Shaw & Co., Inc. | 2,763,776 | $6.74M | 0.01% | +1,480,805+115.4% | Added |
| Boxer Capital Management, LLC | 2,725,000 | $6.65M | 0.87% | +2,725,000 | New |
| AQR Capital Management LLC | 2,484,780 | $6.06M | 0.00% | +1,055,533+73.9% | Added |
| Nuveen, LLC | 2,315,092 | $5.65M | 0.00% | +2,043,085+751.1% | Added |
| MPM Oncology Impact Management LP | 2,242,933 | $5.47M | 0.42% | +2,242,933 | New |
| Renaissance Technologies LLC | 2,139,328 | $5.22M | 0.01% | −47,756−2.2% | Reduced |
| Bank of America Corp | 2,134,473 | $5.21M | 0.00% | +1,127,145+111.9% | Added |
| Jacobs Levy Equity Management, Inc | 2,013,508 | $4.91M | 0.02% | +2,013,508 | New |
| Vanguard Portfolio Management LLC | 1,694,112 | $4.13M | 0.00% | +1,694,112 | New |
| UBS Group AG | 1,604,090 | $3.91M | 0.00% | +214,497+15.4% | Added |
| FMR LLC | 1,589,830 | $3.88M | 0.00% | +144,069+10.0% | Added |
| Standard Life Aberdeen plc | 1,462,219 | $3.57M | 0.01% | −624,113−29.9% | Reduced |
| GordonMD Global Investments LP | 1,430,000 | $3.49M | 2.87% | +1,430,000 | New |
| Charles Schwab Investment Management Inc | 1,396,533 | $3.41M | 0.00% | +40,724+3.0% | Added |
| DAFNA Capital Management LLC | 1,370,118 | $3.34M | 0.76% | −10,000−0.7% | Reduced |
| JPMorgan Chase & Co | 1,434,647 | $3.18M | 0.00% | +455,535+46.5% | Added |
| Northern Trust Corp | 1,285,702 | $3.14M | 0.00% | +87,235+7.3% | Added |
| Dimensional Fund Advisors LP | 1,201,655 | $2.93M | 0.00% | +243,839+25.5% | Added |
| Balyasny Asset Management LLC | 1,182,816 | $2.89M | 0.01% | +1,182,816 | New |
| Vanguard Fiduciary Trust Co | 1,091,809 | $2.66M | 0.00% | +1,091,809 | New |
| Morgan Stanley | 998,845 | $2.44M | 0.00% | +295,707+42.1% | Added |
| Invesco Ltd. | 684,519 | $1.67M | 0.00% | +74,712+12.3% | Added |
| Manufacturers Life Insurance Company, The | 654,180 | $1.60M | 0.00% | +169,558+35.0% | Added |
| TD Asset Management Inc | 652,484 | $1.59M | 0.00% | +238,410+57.6% | Added |
| Voleon Capital Management LP | 640,598 | $1.56M | 0.03% | +640,598 | New |
| Raiffeisen Bank International AG | 700,000 | $1.55M | 0.02% | −200,000−22.2% | Reduced |
| Ieq Capital, LLC | 614,189 | $1.50M | 0.01% | +178,922+41.1% | Added |
| Jane Street Group, LLC | 505,273 | $1.23M | 0.00% | −1,655,110−76.6% | Reduced |
| Algert Global LLC | 463,980 | $1.13M | 0.02% | +267,580+136.2% | Added |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 428,700 | $1.05M | 0.00% | +289,800+208.6% | Added |
| Bank of New York Mellon Corp | 395,187 | $964.3K | 0.00% | −10,656−2.6% | Reduced |
| Creative Planning | 364,809 | $890.1K | 0.00% | +91,425+33.4% | Added |
| Citigroup Inc | 353,335 | $862.1K | 0.00% | −238,617−40.3% | Reduced |
| XTX Topco Ltd | 315,743 | $770.4K | 0.01% | −160,564−33.7% | Reduced |
| Harold Davidson & Associates Inc. | 289,222 | $705.7K | 0.34% | +94,469+48.5% | Added |
| Rafferty Asset Management, LLC | 282,346 | $688.9K | 0.00% | +282,346 | New |
| Headlands Technologies LLC | 265,922 | $648.9K | 0.07% | +219,144+468.5% | Added |
| HSBC Holdings PLC | 260,404 | $638.0K | 0.00% | +112,268+75.8% | Added |
| Bridgeway Capital Management, LLC | 250,000 | $610.0K | 0.01% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 244,592 | $596.8K | 0.00% | +244,592 | New |
| Point72 Asset Management, L.P. | 221,335 | $540.1K | 0.00% | +117,595+113.4% | Added |
| Toroso Investments, LLC | 219,072 | $534.5K | 0.00% | +219,072 | New |
| Tema ETFs LLC | 219,072 | $534.5K | 0.04% | +219,072 | New |
| Rhumbline Advisers | 201,027 | $490.5K | 0.00% | −1,979−1.0% | Reduced |
| Russell Investments Group, Ltd. | 182,344 | $444.9K | 0.00% | +142,303+355.4% | Added |
| Virtus Investment Advisers, Inc. | 180,588 | $440.6K | 0.12% | +4,410+2.5% | Added |
| Public Employees Retirement System of Ohio | 177,875 | $434.0K | 0.00% | +177,875 | New |
| OpenArc Corporate Advisory, LLC | 172,258 | $420.3K | 0.01% | +9,274+5.7% | Added |
| LPL Financial LLC | 172,250 | $420.3K | 0.00% | +1,500+0.9% | Added |
| Partners Capital Investment Group, LLP | 161,597 | $394.3K | 0.01% | 00.0% | Unchanged |
| Barclays PLC | 160,846 | $392.5K | 0.00% | −481,841−75.0% | Reduced |
| Cerity Partners LLC | 157,235 | $383.7K | 0.00% | +59,326+60.6% | Added |
| Man Group plc | 154,683 | $377.4K | 0.00% | −371,423−70.6% | Reduced |
| Gsa Capital Partners LLP | 151,722 | $370.0K | 0.02% | −462,276−75.3% | Reduced |
| CWM, LLC | 147,157 | $359.1K | 0.00% | +84,419+134.6% | Added |
| Nomura Asset Management International Inc. | 146,779 | $358.0K | 0.00% | 00.0% | Unchanged |
| RSM US Wealth Management LLC | 142,649 | $348.1K | 0.00% | +103,800+267.2% | Added |
| Deutsche Bank AG | 128,319 | $313.1K | 0.00% | −2,767−2.1% | Reduced |
| Susquehanna International Group, LLP | 126,760 | $309.3K | 0.00% | +35,507+38.9% | Added |
| Profund Advisors LLC | 125,856 | $307.1K | 0.01% | +125,856 | New |
| Smartleaf Asset Management LLC | 137,874 | $306.1K | 0.01% | +108,947+376.6% | Added |
| Winton Group Ltd | 121,200 | $295.7K | 0.01% | +121,200 | New |
| Alliancebernstein L.P. | 207,518 | $284.3K | 0.00% | −88,980−30.0% | Reduced |
| Squarepoint Ops LLC | 116,379 | $284.0K | 0.00% | +11,723+11.2% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 113,964 | $278.1K | 0.00% | +74,183+186.5% | Added |
| Mariner, LLC | 108,722 | $265.2K | 0.00% | +72,229+197.9% | Added |
| Engineers Gate Manager LP | 105,915 | $258.4K | 0.00% | +105,915 | New |
| Vanguard Global Advisers, LLC | 103,247 | $251.9K | 0.00% | +103,247 | New |
| Polymer Capital Management (US) LLC | 100,676 | $245.6K | 0.04% | +100,676 | New |
| Nwi Management LP | 100,000 | $244.0K | 0.01% | 00.0% | Unchanged |
| Virtu Financial LLC | 98,685 | $241.0K | 0.01% | +56,334+133.0% | Added |
| Wealth Enhancement Advisory Services, LLC | 96,114 | $238.4K | 0.00% | +40,531+72.9% | Added |
| Mirae Asset Global ETFs Holdings Ltd. | 92,886 | $222.3K | 0.00% | +21,435+30.0% | Added |
| Captrust Financial Advisors | 89,938 | $219.4K | 0.00% | +36,837+69.4% | Added |
| Wells Fargo & Company | 89,180 | $217.6K | 0.00% | −111,096−55.5% | Reduced |
| JustInvest LLC | 88,523 | $216.0K | 0.00% | +20,735+30.6% | Added |
| Acadian Asset Management LLC | 88,619 | $214.0K | 0.00% | −906,522−91.1% | Reduced |
| Quadrature Capital Ltd | 81,444 | $198.7K | 0.00% | −192,972−70.3% | Reduced |
| Axq Capital, LP | 73,930 | $180.4K | 0.02% | +73,930 | New |
| MetLife Investment Management | 73,717 | $179.9K | 0.00% | +38,894+111.7% | Added |
| Tudor Investment Corp Et Al | 72,105 | $175.9K | 0.00% | +1,097+1.5% | Added |
| BNP Paribas Arbitrage, SA | 70,965 | $173.2K | 0.00% | −829,459−92.1% | Reduced |